National Cancer Institute
Found 918 results for your search:
Total relevant funding to Leukemia for this search:
$250,547,507
Fiscal Year FY 2017
Cancer Type [Leukemia]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 918 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy 5R21CA205644-02 $202,439 $202,439 WHITESIDE, THERESA UNIVERSITY OF PITTSBURGH AT PITTSBURGH
2
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression 5R01CA205975-02 $386,619 $386,619 GHAFFARI, SAGHI ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
3
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia 1R01CA216273-01 $701,924 $701,924 WU, CATHERINE DANA-FARBER CANCER INST
4
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia 5R01CA185062-04 $312,304 $312,304 FARRAR, MICHAEL UNIVERSITY OF MINNESOTA
5
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data 5R01CA185486-04 $517,690 $258,845 RABADAN, RAUL COLUMBIA UNIVERSITY HEALTH SCIENCES
6
(PQC2) Localization as a determinant of cancer dormancy 5R01CA194596-03 $553,740 $553,740 LIN, CHARLES MASSACHUSETTS GENERAL HOSPITAL
7
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL 5R01CA184922-04 $553,684 $553,684 WU, CATHERINE DANA-FARBER CANCER INST
8
0021.0001 CG 425 METAVIVOR 261200800001E $319,219,481 $27,826 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
9
5-hydroxymethylcytosine in human cancer 5R01CA160965-06 $394,250 $197,125 PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE
10
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $169,821 $67,929 Rothman, Nat DCEG (NCI)
11
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOS ZIA CP010121-10363 $11,686 $11,686 Lan, Qing DCEG (NCI)
12
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia 5R01CA190843-03 $311,458 $155,729 SOHN, LYDIA UNIVERSITY OF CALIFORNIA BERKELEY
13
A Mouse Model of DNMT3A-Associated Hematologic Malignancy 5R01CA183252-04 $533,845 $533,845 GOODELL, MARGARET BAYLOR COLLEGE OF MEDICINE
14
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment 5R00CA183914-04 $254,171 $254,171 WAN, LIXIN H. LEE MOFFITT CANCER CTR & RES INST
15
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease 5R01CA201719-02 $361,504 $180,752 GAMBHIR, SANJIV STANFORD UNIVERSITY
16
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease. 1R44CA221513-01 $1,017,478 $1,017,478 DEVENPORT, MARTIN ONCOIMMUNE, INC.
17
A rapid spontaneous murine model of CN-AML 3R01CA196658-02S1 $234,525 $234,525 GRIMES, H. CINCINNATI CHILDRENS HOSP MED CTR
18
A rapid spontaneous murine model of CN-AML 5R01CA196658-02 $575,500 $575,500 GRIMES, H. CINCINNATI CHILDRENS HOSP MED CTR
19
A Role for KSHV in the Pathogenesis of Malignancies ZIA SC 010356 $317,262 $31,726 Tosato, Giovanna CCR (NCI)
20
AARP prospective study of diet and cancer ZIA CP010196-03152 $703,174 $35,159 Sinha, Rashmi DCEG (NCI)
21
Aberrant signaling in acute myeloid leukemia 3R01CA204396-02S1 $232,133 $232,133 KENTSIS, ALEX SLOAN-KETTERING INST CAN RESEARCH
22
Aberrant signaling in acute myeloid leukemia 5R01CA204396-02 $459,674 $459,674 KENTSIS, ALEX SLOAN-KETTERING INST CAN RESEARCH
23
Abramson Cancer Center Support Grant 3P30CA016520-41S1 $125,000 $6,250 DANG, CHI UNIVERSITY OF PENNSYLVANIA
24
Abramson Cancer Center Support Grant 3P30CA016520-41S2 $62,491 $3,125 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
25
Abramson Cancer Center Support Grant 5P30CA016520-41 $7,810,244 $390,512 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
26
Activation of Proto-Oncogenes by Chromosomal Translocation ZIA SC 010378 $380,330 $190,165 Aplan, Peter CCR (NCI)
27
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment 7R01CA201444-02 $396,181 $396,181 MITTELMAN, STEVEN UNIVERSITY OF CALIFORNIA LOS ANGELES
28
Adoptive T cell Therapy for Pediatric Leukemia ZIA BC 011565 $776,399 $776,399 Fry, Terry CCR (NCI)
29
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations 3R33CA192980-03S1 $77,458 $77,458 SALIPANTE, STEPHEN UNIVERSITY OF WASHINGTON
30
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations 5R33CA192980-03 $375,858 $375,858 SALIPANTE, STEPHEN UNIVERSITY OF WASHINGTON
31
Aging-associated alterations in adaptive landscapes and the evolution of leukemia 5R01CA180175-05 $344,920 $344,920 DEGREGORI, JAMES UNIVERSITY OF COLORADO DENVER
32
Agricultural Cohort Consortium ZIA CP010119-10537 $50,451 $10,090 Beane Freeman, Laura DCEG (NCI)
33
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture ZIA CP010119-10527 $1,244,533 $248,907 Hofmann, Jonathan DCEG (NCI)
34
ALL immunobiology and the bone marrow niche ZIA BC 011295 $332,742 $332,742 Fry, Terry CCR (NCI)
35
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-04S1 $2,088,480 $313,272 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
36
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-04 $11,145,123 $1,671,768 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
37
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $13,582 $9,100 Kochenderfer, James CCR (NCI)
38
Ambient dioxin exposure and cancer risk in women (IWHS and AHS) ZIA CP010125-10712 $56,170 $11,234 Jones, Rena DCEG (NCI)
39
AML-MutationCounter, a tool to detect residual and recurrent leukemia 1R41CA213690-01 $220,087 $220,087 KAUFMANN, WILLIAM ASYSTBIO LABORATORIES, LLC
40
Analysis of circulatory disease after low dose or low dose rate radiation exposur ZIA CP010222-10738 $25,339 $25,339 Little, Mark DCEG (NCI)
41
Analysis of TET2 function in acute leukemia 5K08CA181507-02 $180,036 $180,036 SHIH, ALAN SLOAN-KETTERING INST CAN RESEARCH
42
Analysis of the novel phenomenon of antibody-mediated fratricide in Acute Myeloid Leukemia 1F30CA217006-01 $39,139 $39,139 FATEHCHAND, KAVIN OHIO STATE UNIVERSITY
43
Anatomic Pathology Residency Program ZIE BC 011384 $1,094,457 $43,778 Barr, Frederic CCR (NCI)
44
Anticancer peptide therapeutics 1R01CA219150-01 $353,419 $353,419 LU, WUYUAN UNIVERSITY OF MARYLAND BALTIMORE
45
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY 1R01CA211711-01 $388,615 $388,615 DRULEY, TODD WASHINGTON UNIVERSITY
46
ARID5B and disparities of childhood leukemia 3U01CA176063-04S1 $99,290 $99,290 YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL
47
ARID5B and disparities of childhood leukemia 5U01CA176063-04 $368,510 $368,510 YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL
48
Assay Development for NSD1 Methyltransferase Inhibitor Discovery 5R01CA191077-03 $312,244 $312,244 KOLB, EDWARD ALFRED I. DU PONT HOSP FOR CHILDREN
49
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS 5R01CA163653-05 $311,165 $311,165 KOPAN, RAPHAEL CINCINNATI CHILDRENS HOSP MED CTR
50
ATBC Lymphoma Studies ZIA CP010195-10733 $23,111 $3,467 Berndt, Sonja DCEG (NCI)
Total relevant funding to Leukemia for this search: $250,547,507
Showing 1 - 50 of 918 results
Go to top